Why participate?
Present the methodology and regulatory considerations required to successfully conduct a clinical trial.
Gain an overall understanding of the clinical development phases.
Training Context:
The clinical phases represent the final and longest stages in the development cycle of a biopharmaceutical. They are essential for evaluating the product’s safety and efficacy in humans. These stages are critical, as many projects are abandoned due to lack of efficacy, and it is often at this point that biotech companies seek to license their candidates to pharmaceutical groups.
Success depends on careful planning, robust trial design, and compliance with strict regulations set by agencies such as the FDA or EMA. Effective data management, clear communication with regulators, and adherence to Good Clinical Practices (GCP) are also crucial to securing final product approval.
Interactive Teaching, Case Studies, Experience Sharing
R&D professionals, project managers, business developers, engineers, clinicians.
Good knowledge of biotechnology and/or therapeutic antibodies, or completion of the training courses “Development of a Biopharmaceutical Candidate” and “Pharmacological Studies in the Preclinical Development of Antibodies.”
Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.
Participant satisfaction rate :
Return rate of satisfaction questionnaires :
Registering online or by e-mail is a pre-registration. We will process your request within one week:
Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.
When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.
For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr
